Wells Fargo & Company Guardant Health, Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Guardant Health, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 177,004 shares of GH stock, worth $9.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

177,004

Previous 18,700 846.55%

Holding current value

$9.75 Million

Previous $571,000 1220.49%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$31.77 - $49.94 $882,411 - $1.39 Million	27,775 Added 18.61%	177,004 $7.54 Million
Q4 2024 Feb 12, 2025	BUY	$20.2 - $38.11 $1.82 Million - $3.44 Million	90,240 Added 152.98%	149,229 $4.56 Million
Q3 2024 Nov 13, 2024	SELL	$22.3 - $36.29 $113,061 - $183,990	-5,070 Reduced 7.91%	58,989 $1.35 Million
Q2 2024 Aug 13, 2024	SELL	$16.07 - $31.84 $282,510 - $559,747	-17,580 Reduced 21.53%	64,059 $1.85 Million
Q1 2024 May 10, 2024	SELL	$17.13 - $26.91 $4.92 Million - $7.72 Million	-286,960 Reduced 77.85%	81,639 $1.68 Million
Q4 2023 Feb 09, 2024	SELL	$21.58 - $29.5 $1.17 Million - $1.6 Million	-54,226 Reduced 12.82%	368,599 $9.97 Million
Q3 2023 Nov 13, 2023	SELL	$25.8 - $39.97 $838,912 - $1.3 Million	-32,516 Reduced 7.14%	422,825 $12.5 Million
Q2 2023 Aug 15, 2023	BUY	$20.94 - $38.01 $1.76 Million - $3.2 Million	84,185 Added 22.68%	455,341 $16.3 Million
Q1 2023 May 12, 2023	BUY	$22.92 - $33.76 $1.03 Million - $1.52 Million	44,878 Added 13.75%	371,156 $8.7 Million
Q4 2022 Feb 13, 2023	SELL	$25.44 - $59.78 $1.6 Million - $3.75 Million	-62,704 Reduced 16.12%	326,278 $8.87 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $1.13 Million - $1.58 Million	25,894 Added 7.13%	388,982 $20.9 Million
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $189,203 - $507,802	-6,565 Reduced 1.78%	363,088 $14.6 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $453,743 - $945,007	9,404 Added 2.61%	369,653 $24.5 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $85.9 Million - $117 Million	-968,192 Reduced 72.88%	360,249 $36 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $3.81 Million - $5.1 Million	-38,602 Reduced 2.82%	1,328,441 $166 Million
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $5.33 Million - $8.04 Million	-48,528 Reduced 3.43%	1,367,043 $170 Million
Q1 2021 May 13, 2021	BUY	$127.04 - $179.1 $4.71 Million - $6.64 Million	37,049 Added 2.69%	1,415,571 $216 Million
Q4 2020 Feb 09, 2021	BUY	$99.96 - $135.93 $12.5 Million - $17 Million	125,153 Added 9.99%	1,378,522 $178 Million
Q3 2020 Nov 05, 2020	BUY	$80.32 - $111.8 $59.7 Million - $83.1 Million	743,619 Added 145.88%	1,253,369 $140 Million
Q2 2020 Aug 13, 2020	SELL	$60.49 - $97.5 $2.19 Million - $3.54 Million	-36,274 Reduced 6.64%	509,750 $41.4 Million
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $32.2 Million - $48.5 Million	546,024 New	546,024 $38 Million

Others Institutions Holding GH

# of Institutions

405

Shares Held

128M

Call Options Held

1.51M

Put Options Held

2.44M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $5.63B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Guardant Health, Inc. Transaction History